ICH M9 - reverse engineering? [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2020-09-30 09:27 (1155 d 11:57 ago) – Posting: # 21951
Views: 905

Dear Marta!

Pls find the recent presentation by FDA on - From General Q1/Q2 Inquiries to Supporting Complex Excipient Sameness. It can be downloaded from - https://sbiaevents.com/files2/Innov-2020-Day-1.zip and see- D1S14-Kozak. It will be useful for BCS based biowaiver approach as well.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,640 registered users;
16 visitors (0 registered, 16 guests [including 8 identified bots]).
Forum time: 20:25 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5